LifeTech Scientific Corporation (HKG:1302)

Market Cap	8.75B
Revenue (ttm)	1.39B
Net Income (ttm)	236.66M
Shares Out	4.63B
EPS (ttm)	0.05
PE Ratio	34.97
Forward PE	19.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,304,000
Average Volume	28,002,300
Open	1.920
Previous Close	1.890
Day's Range	1.840 - 1.930
52-Week Range	1.240 - 2.070
Beta	1.19
RSI	74.43
Earnings Date	Aug 28, 2025

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company’s products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,395
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1302

Financial Performance

In 2024, LifeTech Scientific's revenue was 1.30 billion, an increase of 2.88% compared to the previous year's 1.27 billion. Earnings were 222.39 million, a decrease of -15.52%.

Financial numbers in CNY